What question did this study set out to answer?

This research aims to understand how CHD4 and NKX2.2 regulate β-cell function in the pancreas.

May 6, 2026Diabetes0 citations

CHD4 and NKX2.2 Cooperate to Regulate β-Cell Function by Repressing Non–β-Cell Gene Programs

DSDylan Sarbaugh TOThais Oliveira MGMichelle A. Guney

Key Points

This research aims to understand how CHD4 and NKX2.2 regulate β-cell function in the pancreas.
Investigated the interaction between NKX2.2 and CHD4
Analysed β-cell function in mice with deleted CHD4
Examined the effects on calcium signaling and insulin secretion
Assessed GIRK4 potassium channel regulation
CHD4 deletion leads to diabetes due to loss of islet integrity
Disrupted calcium signaling found in CHD4-deficient β-cells
Impaired insulin secretion observed in conditions lacking CHD4
Inhibition of GIRK4 rescues the insulin secretion defect

Abstract

ARTICLE HIGHLIGHTS: NKX2.2 interacts with the nucleosome remodeling and deacetylase complex through its interaction with chromodomain helicase DNA-binding protein 4 (CHD4). Deletion of CHD4 from developing pancreatic β-cells in mice causes diabetes due to a loss of islet integrity, disrupted calcium signaling, and impaired insulin secretion. β-cells lacking CHD4 inappropriately upregulate the G protein-activated inward rectifier potassium channel 4 (GIRK4) potassium channel; inhibition of GIRK4 rescues the insulin secretion defect.

KI fragen

Bookmark

View Full Paper

Cite This Study

Sarbaugh et al. (Mon,) studied this question.

synapsesocial.com/papers/69fa8eca04f884e66b5313cf https://doi.org/https://doi.org/10.2337/db25-0945

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper